Remus Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	335.1	290.7	205.2	85.03	34.34	10.26
Depreciation & Amortization	24.4	18.6	11	4.64	1.55	1.75
Other Amortization	0.1	0.1	0.2	0.13	-	-
Loss (Gain) From Sale of Assets	-	-2.1	-	-	-	-
Other Operating Activities	114.4	93.6	21.7	-3.93	-1.72	-0.66
Change in Accounts Receivable	-879.9	72.6	-481.2	-19.33	6.89	-19.77
Change in Inventory	-676.6	-84.4	-7.7	13.02	-4.39	-7.14
Change in Accounts Payable	873.9	-224.1	390.2	-15.07	14.97	48.01
Change in Other Net Operating Assets	276.1	-95.2	-125.9	-11.36	-1.26	-4.07
Operating Cash Flow	67.8	69.8	13.5	53.13	50.38	28.38
Operating Cash Flow Growth	-	417.04%	-74.59%	5.46%	77.52%	117.86%
Capital Expenditures	-45.4	-39.8	-32.9	-27.32	-0.71	-0.66
Sale of Property, Plant & Equipment	-	3	-	-	-	-
Cash Acquisitions	-	-	-87.3	-	-	-
Investment in Securities	-154.3	2.7	32.6	-175.48	-30.01	-0.67
Other Investing Activities	18.4	-42.5	-178.3	3.45	2.44	0.69
Investing Cash Flow	-128.6	-105.5	-301.1	-151.92	-45.45	-30.9
Short-Term Debt Issued	-	89.3	-	-	-	-
Long-Term Debt Issued	-	3.3	23.5	77.51	-	-
Total Debt Issued	20.4	92.6	23.5	77.51	-	-
Short-Term Debt Repaid	-	-	-6.4	-	-	-
Long-Term Debt Repaid	-	-5.1	-58.6	-	-0.87	-0.8
Total Debt Repaid	-93.1	-5.1	-65	-	-0.87	-0.8
Net Debt Issued (Repaid)	-72.7	87.5	-41.5	77.51	-0.87	-0.8
Issuance of Common Stock	-	-	467	42.5	-	-
Common Dividends Paid	-5.9	-11.8	-5.9	-	-	-
Other Financing Activities	-13	-15	-142.9	-2.33	-0.87	-0.35
Financing Cash Flow	-91.6	60.7	276.7	117.69	-1.74	-1.15
Miscellaneous Cash Flow Adjustments	0.1	0.1	48	0	-	0
Net Cash Flow	-152.3	25.1	37.1	18.9	3.18	-3.68
Free Cash Flow	22.4	30	-19.4	25.81	49.67	27.72
Free Cash Flow Growth	-	-	-	-48.03%	79.21%	272.81%
Free Cash Flow Margin	0.30%	0.48%	-0.91%	5.72%	20.09%	14.74%
Free Cash Flow Per Share	1.83	2.55	-1.72	3.16	6.21	3.46
Cash Interest Paid	14.6	14.6	5	2.33	0.87	0.35
Cash Income Tax Paid	74.7	74.7	58.1	29.97	11.94	3.65
Levered Free Cash Flow	-309.37	-108.75	-394.05	7.45	42.87	24.7
Unlevered Free Cash Flow	-301.31	-99.63	-390.92	8.73	43.36	24.88
Change in Working Capital	-406.5	-331.1	-224.6	-32.74	16.21	17.03

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.